Participated · Series C · Nov 2023

Neurophet develops AI-driven medical software for neurology, including brain MRI and PET analysis, stimulation simulation, and region-of-interest research tools. Its product suite includes Neurophet AQUA (brain MRI imaging analysis), Neurophet SCALE PET (brain PET scan analysis), Neurophet tES/TMS Lab (stimulation simulation), and Neurophet SegPlus (ROI research tool). The company focuses on diagnosis support, treatment guides, and treatment-device software for brain diseases using advanced AI. In November 2023 Neurophet secured KRW 20.0 billion in a Series C financing. The firm plans to use the funds to release a comprehensive Alzheimer’s dementia solution next year. The funding is intended to support continued product development and commercial rollout of its AI-driven brain imaging offerings.

Participated · Series B · Oct 2019

Market Designers builds on-demand matching platforms that generate and provide trustworthy information to create fair, transparent marketplaces. Its two core products are Wematch, an on-demand housing-matching platform, and Tutoring, a real-time global tutor-student connection service. Wematch reported 5 million cumulative visitors as of September and recently beta-launched Wematch Interior; Tutoring has recorded 1 million cumulative members, with total site visits across services reaching 6 million. The company says its proprietary data and matching technology drive rapid expansion in both housing and education verticals. Market Designers was recognized in August by the Korea Credit Guarantee Fund’s 'Innovation Icon' program for startups with high unicorn potential. Management plans to use the new funding to expand Wematch into new categories and to push Tutoring’s global market expansion. The company has grown through prior Series A and bridge investments to date.